by Oh Jooyean
Published 09 May.2024 10:42(KST)
On the 8th, the Ministry of Food and Drug Safety (MFDS) announced on the 9th that it held a bilateral meeting with the United Arab Emirates (UAE) Medicines and Medical Devices Regulatory Authority (EDE) at COEX in Gangnam-gu, Seoul, to discuss ways to strengthen mutual cooperation in the medical products sector between the two countries.
EDE, newly established in December last year, is a regulatory agency responsible for the approval and safety management of pharmaceuticals, medical devices, cosmetics, and health supplements within the UAE.
According to the MFDS, during the meeting, EDE showed great interest in South Korea's advanced biopharmaceutical sector. The MFDS shared laws, systems, and regulatory experiences related to advanced biopharmaceuticals and proposed the inclusion of South Korea in the reference country list to facilitate the expedited approval of Korean medical products in the UAE.
Shin Jun-su, Director of the Bio-Pharmaceutical Division at MFDS, and Fatima Al Kaabi, EDE’s Chief Executive Officer, discussed specific cooperation measures such as sharing regulatory experiences for medical products and establishing regular communication channels, agreeing to pursue a memorandum of understanding (MOU) in the future.
Both parties signed a record of agreement reflecting these discussions, laying the foundation for cooperation between the two agencies.
The MFDS expects that the signing of this record of agreement will help activate exports of medical products to the UAE and the Middle East region.
The MFDS stated, "We will continue to actively promote regulatory diplomacy to strengthen cooperation with global regulatory authorities and do our best to support the active entry of excellent domestic medical products into overseas markets."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.